Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in Patients With Diabetes and Heart Failure With Normal Left Ventricular Ejection Fraction
NCT00799435Phase 4Terminated
- Sponsor
- Baylor College of Medicine
- Start
- Jul 2009
- Primary completion
- Apr 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in heart failure with preserved ejection fraction (HFpEF), sponsored by Baylor College of Medicine. Started Jul 2009; status: terminated.
02
Drugs
exenatide
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT00799435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799435.